Belapectin (GR-MD-02) is a proprietary galactoarabino-rhamnogalacturonan polysaccharide polymer comprising galacturonic acid, galactose, arabinose, rhamnose and
Galectins are a class of proteins made by many cells in the body, but predominantly in cells of the immune system. As a group, these proteins are able to bind t
The NAVIGATE clinical trial is a study clinically focused on MASH cirrhosis, for which there are no approved therapies short of a liver transplant. The NAVIGATE
MASH Cirrhosis MASH cirrhosis is the end stage of Metabolic Dysfunction-Associated Steatohepatitis (MASH), where the scar tissue and regenerative nodules result
Publications on MASH Cirrhosis Naim Alkhouri, Raj Vuppalanchi, Mazen Noureddin, Eric Lawitz, Edward Mena, Nadege T. Gunn, Khurram Jamil, Seth Zuckerman, Stephen
Scope This policy applies to expanded access and compassionate use requests for investigational products with active ingredients that have not been approved for
Effective Date: October 1,2013 Last Updated: January 28, 2021 Galectin Therapeutics Inc. (“Galectin Therapeutics” or the “Company”) provides the materials on th
